PRCNF - Pure Global Cannabis Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1980
-0.0020 (-1.02%)
As of 10:25AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.2000
Open0.2000
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.1900 - 0.2100
52 Week Range0.0200 - 0.5000
Volume176,300
Avg. Volume168,071
Market Cap29.876M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.19700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE10 days ago

    The Cannabis Boom Will be a Boon for these Three Top Stocks

    In fact, it'll allow for hemp cultivation and the transfer of hemp products across state lines for commercial and other purposes, notes Forbes. Most notably, some of top companies that could realize its benefits, include Pure Global Cannabis Inc. (TSX.V: PURE) (OTC PINK: PRCNF), Tilray Inc. (NASDAQ: TLRY), and Canopy Growth Corporation (NYSE: CGC)(TSX: WEED). Pure Global Cannabis' (PURE)(PRCNF) subsidiary, PureSinse Inc. and Emerald Plants Health Source just announced the companies have entered into a cannabis supply agreement where Pure Global will purchase 1,000kg of dried flower from EPHS.

  • CNW Group10 days ago

    Pure Global Signs MOU for Supply Agreement with Craft Cannabis Experts: Emerald Plants Health Source

    FRA:1QS) (the "Pure Global") an integrated, growth-oriented life sciences and consumer products cannabis company, operating through its wholly-owned subsidiary PureSinse Inc. ("PureSinse" or "Company"), and Emerald Plants Health Source (OCTQB: STNN: EPHS Holdings Inc.) ("EPHS") are pleased to announce that the companies have entered into a memorandum of understanding ("MOU") through which the parties shall seek to enter into a cannabis wholesale supply agreement ("Supply Agreement") whereby PureSinse will purchase 1,000 kg of dried flower from EPHS.

  • CNW Group21 days ago

    Pure Global Cannabis Announces DTC Eligibility

    Pure Global Cannabis Announces DTC Eligibility

  • ACCESSWIRE23 days ago

    Three Top Medical Marijuana Stocks to Watch as Market Balloons to $500 billion

    CORAL GABLES, FL / ACCESSWIRE / January 29, 2019 / With the cannabis boom just getting underway, analysts at Piper Jaffray believe we could be looking at a market value of between $250 billion to $500 billion a year. ''We believe the long-term growth can be significant - both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health [and] wellness categories to CBD-infused products,'' said the analysts, as quoted by MarketWatch. Some of those companies include Pure Global Cannabis Inc. (TSX.V: PURE) (OTC PINK: PRCNF), CannTrust Holdings Inc. (TSX: TRST) (OTC: CNTTF), and Canopy Growth Corporation (NYSE: CGC) (TSX: WEED).

  • CNW Group23 days ago

    Pure Global Cannabis to Acquire SPARK Cannabis Clinic and Engages HelloMD to Accelerate Patient Acquisition

    FRA:1QS) (the "Company" or "Pure Global") an integrated, growth-oriented life sciences and consumer products cannabis company, through its wholly-owned subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce it has entered into a definitive agreement to purchase all of the outstanding shares of SPRQ Health Group Corp. o/a SPARK ( "SPARK"),  a Brampton -based cannabis clinic helping  patients to obtain safe access to medical cannabis with in-clinic, telephone, and telehealth based consultations (the "Transaction"). SPARK will operate as a wholly-owned subsidiary of Pure Global. Headed by Dr. Sanjeev Goel , SPARK commenced providing medical cannabis services in September 2017 , and currently cares for over 2,500 active patients.

  • ACCESSWIRE29 days ago

    Three of the Most Innovative Medical Marijuana Stocks to Know

    HOUSTON, TX / ACCESSWIRE / January 23, 2019 / The global cannabis market is still in the early innings of a multi-year boom. Thanks in large part to growing acceptance of cannabis - including Canada's legalization in October 2018, further U.S. state approval, and growing interest from corporate America the global market is expected to reach $146.4 billion by 2025, according to Grand View Research Inc. from $7.06 billion in 2016. In addition, the growing adoption of cannabis in medical applications such as cancer, mental disorders, and chronic pain is expected to propel revenue growth even more.

  • CNW Group29 days ago

    Pure Global launches e-store at PureSinse.com to begin serving cannabis patients from across Canada

    FRA:1QS) (the "Company" or "Pure Global") an integrated, growth-oriented life sciences and cannabis consumer products company, through its operating subsidiary PureSinse Inc. ("PureSinse"), is announcing the launch of its e-store at PureSinse.com, subsequent to receiving its Sales License from Health Canada on January 11, 2019 . The online store is ready to service physicians and register medical cannabis patients from across Canada who hold a valid medical document. Once registered, patients can purchase quality tested premium legal cannabis products from PureSinse for secure discreet courier delivery.

  • CNW Grouplast month

    Pure Global launches the Clinical Cannabinoid Education Network (CCEN)

    Pure Global launches the Clinical Cannabinoid Education Network (CCEN)

  • ACCESSWIRElast month

    The Biggest Medicinal Cannabis Developments of 2019

    Canada became the first country in the industrialized world to legalize recreational marijuana. In fact, Cowen, U.S. cannabis sales alone could reach $80 billion by 2030- an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate. Piper Jaffray believes the market for legal cannabis could be worth $15 billion to $50 billion a year, with global sales growing to $250 billion to $500 billion.

  • CNW Grouplast month

    /R E P E A T -- Pure Global Cannabis Awarded Health Canada Sales License/

    FRA:1QS) (the "Company" or "Pure Global") an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is excited to announce that Health Canada has issued PureSinse a Sales License under the Cannabis Act. Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need.

  • CNW Grouplast month

    Pure Global Cannabis Awarded Health Canada Sales License

    FRA:1QS) (the "Company" or "Pure Global") an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is excited to announce that Health Canada has issued PureSinse a Sales License under the Cannabis Act. Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need.

  • Pure Global Hires Veteran from Alcohol Beverage Industry as VP Sales & Marketing
    CNW Group3 months ago

    Pure Global Hires Veteran from Alcohol Beverage Industry as VP Sales & Marketing

    FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce that Ross J. Hendry , formerly of Corby Spirit and Wine, has joined as Vice President of Sales and Marketing. Ross Hendry has been a driving force in the Canadian alcohol beverage industry for more than a decade. Hendry comes to Pure Global after serving as Commercial Director, International Canadian Spirits, at Corby Spirit and Wine, where he oversaw marketing and strategic business development for more than 40 brand/market combinations in 13 international markets.

  • Pure Global Cannabis Launching Medical Product Line With Research Driven Approach
    CNW Group3 months ago

    Pure Global Cannabis Launching Medical Product Line With Research Driven Approach

    FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce the readiness of eight product lines in eco-friendly packaging for medical cannabis patients. PureSinse will begin sales to medical patients soon after Health Canada has granted it a Sales License, which is anticipated in the coming weeks. PureSinse is committed to providing medical cannabis patients with medical cannabis products despite the high demands of the legal adult markets, which also represents a higher margin sales channel for the Company.

  • CNW Group4 months ago

    Pure Global Cannabis announces hire of three senior team members

    FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce that it has made three new hires to help with company's operations and the production of expanded PureSinse offerings: Sandra Couto as Clinical Affairs Lead, Cheryl Pim as Director of New Product Development, and Joseph Choi as Controller. Pure Global's new Clinical Affairs Lead, Sandra Couto , has been a driving force in the Canadian pharmaceutical sector for more than twenty years.

  • CNW Group4 months ago

    Pure Global Cannabis completes pre-licensing sales inspection

    FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis Company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce that Health Canada has completed its physical on-site inspection required to issue a sales license to PureSinse. Upon final approvals over the coming weeks, PureSinse will be granted a sales license under the Cannabis Act, formerly the Access to Cannabis for Medical Purposes Regulations (ACMPR).

  • CNW Group4 months ago

    Pure Global Announces Termination of Letter of Intent

    Pure Global Announces Termination of Letter of Intent

  • CNW Group4 months ago

    Pure Global Cannabis Adds Chief Medical Officer to Core Team

    FRA:1QS) (the "Company" or "Pure Global" or "PURE"), through its subsidiary PureSinse Inc., ("PureSinse"), is pleased to announce that Dr. Sanjeev Goel , a leading physician in medical cannabis has joined the PureSinse team as Chief Medical Officer. Dr. Goel has a wealth of experience in medical cannabis and a pioneer in medical cannabis since 2015.

  • CNW Group4 months ago

    Pure Global CEO Malay Panchal to Speak at Canadian Cannabis Capital Markets Conference in Germany

    Pure Global CEO Malay Panchal to Speak at Canadian Cannabis Capital Markets Conference in Germany

  • CNW Group4 months ago

    Pure Global Acquires State-of-the-Art Cannabis Oil Extraction and High-Speed Robotic Filling Equipment

    Pure Global Acquires State-of-the-Art Cannabis Oil Extraction and High-Speed Robotic Filling Equipment

  • CNW Group5 months ago

    Pure Global CEO Malay Panchal to Speak at Cannabis Invest Conferences in London and Geneva

    Pure Global CEO Malay Panchal to Speak at Cannabis Invest Conferences in London and Geneva

  • CNW Group5 months ago

    Pure Global Completes Initial Sales License Review and Launches Groundbreaking Medical Cannabis Research Study with Appletree Medical Group

    Pure Global Completes Initial Sales License Review and Launches Groundbreaking Medical Cannabis Research Study with Appletree Medical Group

  • CNW Group5 months ago

    Pure Global Cannabis Announces Listing on Frankfurt Stock Exchange

    Pure Global Cannabis Announces Listing on Frankfurt Stock Exchange

  • CNW Group5 months ago

    Pure Global Cannabis Completes $10 Million Financing

    Pure Global Cannabis Completes $10 Million Financing

  • CNW Group5 months ago

    Pure Global Cannabis to join as launch partner to BuyWell.com marketplace for alternative health products and provides debenture financing update

    OTC: PRCNF)  (the "Company" or "Pure Global" or "PURE") is pleased to announce that it has entered into a Memorandum of Understanding with Evergreen Pacific Insurance Corp. ("Evergreen Pacific") pursuant to which  Pure Global's wholly owned subsidiary, PureSinse Inc. ("PureSinse"), will become a merchant partner for the launch of BuyWell.com, which aims to be the preeminent Canadian marketplace for health and wellness products and services. PURE will engage with BuyWell.com customers for making available medical cannabis products and a broad range of paramedical extracts on its e-marketplace. BuyWell.com, a subsidiary of Evergreen Pacific, is launching its e-marketplace in September 2018 , which will include more than 10,000 curated health and wellness products and services, to be marketed to the discerning alternative health consumer.